NCOA4对KRAS G12C突变型胰腺癌靶向抑制剂获得性耐药的影响及其机制
常昊1 王亚南1 刘世海2 王静1
Role and mechanism of action of nuclear receptor coactivator 4 in the development of acquired resistance to targeted inhibitors in pancreatic cancer with KRAS G12C mutation
CHANG Hao, WANG Ya′nan, LIU Shihai, WANG Jing
精准医学杂志
.
0, (): 1
.
